China National Accord Medicines Corp Ltd (000028) — Cash Flow-to-Debt Ratio
China National Accord Medicines Corp Ltd (000028) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of CN¥-425.23 Million could theoretically repay 0% of its total liabilities (CN¥29.01 Billion) in one year. Explore China National Accord Medicines Corp Ltd (000028) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
China National Accord Medicines Corp Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for China National Accord Medicines Corp Ltd across 27 annual periods. Also explore 000028 asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for China National Accord Medicines Corp Ltd (1998–2024)
Year-by-year debt coverage analysis for China National Accord Medicines Corp Ltd. For market capitalisation and broader financial context, see China National Accord Medicines Corp Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.12x | CN¥3.27 Billion | CN¥26.80 Billion | ▲ +10.5% |
| 2023 | 0.11x | CN¥2.94 Billion | CN¥26.59 Billion | ▼ 0.0% |
| 2022 | 0.11x | CN¥2.56 Billion | CN¥23.17 Billion | ▲ +65.3% |
| 2021 | 0.07x | CN¥1.66 Billion | CN¥24.76 Billion | ▲ +1.0% |
| 2020 | 0.07x | CN¥1.50 Billion | CN¥22.71 Billion | ▼ -39.9% |
| 2019 | 0.11x | CN¥2.00 Billion | CN¥18.16 Billion | ▲ +25.1% |
| 2018 | 0.09x | CN¥1.32 Billion | CN¥15.02 Billion | ▼ -15.0% |
| 2017 | 0.10x | CN¥1.29 Billion | CN¥12.42 Billion | ▼ -12.8% |
| 2016 | 0.12x | CN¥1.47 Billion | CN¥12.40 Billion | ▼ -13.3% |
| 2015 | 0.14x | CN¥1.05 Billion | CN¥7.65 Billion | ▲ +237.1% |
| 2014 | -0.10x | CN¥-796.70 Million | CN¥7.98 Billion | ▼ -287.7% |
| 2013 | 0.05x | CN¥465.03 Million | CN¥8.74 Billion | ▲ +22.5% |
| 2012 | 0.04x | CN¥323.96 Million | CN¥7.46 Billion | ▲ +19.2% |
| 2011 | 0.04x | CN¥227.32 Million | CN¥6.24 Billion | ▼ -56.0% |
| 2010 | 0.08x | CN¥428.16 Million | CN¥5.18 Billion | ▲ +33.0% |
| 2009 | 0.06x | CN¥270.85 Million | CN¥4.36 Billion | ▼ -23.5% |
| 2008 | 0.08x | CN¥246.58 Million | CN¥3.03 Billion | ▲ +121.3% |
| 2007 | 0.04x | CN¥87.70 Million | CN¥2.39 Billion | ▼ -55.4% |
| 2006 | 0.08x | CN¥181.73 Million | CN¥2.21 Billion | ▼ -62.3% |
| 2005 | 0.22x | CN¥148.28 Million | CN¥678.73 Million | ▼ -18.2% |
| 2004 | 0.27x | CN¥130.30 Million | CN¥487.99 Million | ▲ +118.8% |
| 2003 | 0.12x | CN¥81.22 Million | CN¥665.47 Million | ▲ +204.6% |
| 2002 | 0.04x | CN¥28.76 Million | CN¥717.90 Million | ▼ -57.6% |
| 2001 | 0.09x | CN¥71.16 Million | CN¥753.72 Million | ▼ -4.9% |
| 2000 | 0.10x | CN¥8.52 Million | CN¥85.83 Million | ▼ -62.3% |
| 1999 | 0.26x | CN¥22.84 Million | CN¥86.72 Million | ▲ +477.0% |
| 1998 | 0.05x | CN¥5.21 Million | CN¥114.11 Million | — |